Moms with placenta accreta who undergo insertion of prophylactic arterial balloons reduce risk of complications with delivery and future fertility.
Prophylactic placement of arterial balloons prior to performing a Caesarean section in patients with placenta accreta preserves the uterus, according to new study presented this week at the annual meeting of the Radiological Society of North America (RSNA).
Researchers from Ireland performed a retrospective chart review in order to assess maternal and fetal outcomes from the placement of a prophylactic internal iliac balloon under fluoroscopic guidance among patients with placenta accreta, immediately prior to undergoing elective Caesarean sections.
"Massive obstetric hemorrhage is the number one cause of maternal mortality worldwide and abnormal placental implantation is a major risk factor for this," Patrick Nicholson, MB, BCh, interventional radiologist trainee, Cork University Hospital, said in a release.
A total of 21 patients with placenta accreta or a variant thereof underwent balloon placement at the researchers’ facility over a 44-month period, starting in 2009. Patient mean age was 35, average gestational age was 37 weeks, mean gravidity was 2.8, and mean number of Caesarian sections was 2.4. Mean intraoperative blood loss was 1.4 liters, and the mean number of blood units transfused was two.
Of the 21 deliveries, arterial balloons were inflated in 13, and were deflated and removed when no longer necessary.
Results showed that 23 live infants were delivered with mean Apgar scores of 8.9 at one minute and 9.6 at 10 minutes. No maternal or fetal complications due to the procedure were noted, although two patients did require a hysterectomy.
"Without the balloons, many more of the patients would likely have required a hysterectomy," Nicholson said in the release.
The researchers concluded that prophylactic placement of an internal iliac balloon is a potentially life-saving, fertility preserving procedure that is safe for both mother and infant.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.